UPB insider buying & filings

UPBUpstream Bio, Inc.

NasdaqGS · Healthcare · $314.39M

$5.75

-3.52% · Sep 10

5 insider filings on record.
None of them an open-market buy in the last year.

Last Form 4 Jan 6 · scanned 5m ago

Price · 1Y · dailyNo open-market activity in range

▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

Market cap

$314.39M

Float

42.8M

78% public

Short % float

Pro

Price / profit

—

not yet profitable

Price / future profit

—

Price / sales

99.6

Institutional stakes

▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing

2 filingsnewest first

13G/ANorges Bank7.7%Aug 12

13GBlackRock, Inc.5.2%Jul 30

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Jan 6GRANTSutherland Everett RandChief Executive Officerdirect75,000 sh—

Jan 6GRANTHoughton AdamChief Business Officerdirect25,000 sh—

Jan 6GRANTGray MichaelCFO and COOdirect30,500 sh—

Jan 6GRANTDeykin AaronChief Medical Officerdirect32,000 sh—

Jan 6GRANTAmbrose AllisonGeneral Counseldirect17,000 sh—

The file stays open

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice